Guy Harmelin M.D.

Guy has served as a member of our Board of Directors since 2018.
Guy is an entrepreneur and investor and has invested and worked with multiple successful companies including Lemonade (LMND:NYSE), Innoviz (INVZ:NASDAQ), American Well (AMWL:NYSE), Ecoppia (ECPA:TLV, Ayala Pharma (AYLA:NASDAQ), Quantum Machines, Tabit, Assured Allies and Oxford Nanopore. Guy was the Co-Founder and CEO of RondinX, a computational drug target discovery company (merged with BiomX and went public PHGE:NYSE). Prior to RondinX, Guy served as a Resident Physician at Tel Aviv Medical center.